Biostar Pharmaceuticals, Inc. (BSPM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Biostar Pharmaceuticals Market Cap
Biostar Pharmaceuticals has a market cap or net worth of $131.86 thousand as of August 1, 2025. Its market cap has decreased by -31.22% in one year.
Market Cap
131.86K
Enterprise Value
n/a
Revenue
317.79K
Ranking
n/a
PE Ratio
0.15
Stock Price
$0.00
Market Cap Chart
Since December 18, 2008, Biostar Pharmaceuticals's market cap has decreased from 38.77M to 131.86K, a decrease of -99.66%. That is a compound annual growth rate of -28.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 131.86K | 4,395,200.00% |
| Dec 30, 2024 | 3.00 | - |
| Dec 30, 2022 | 3.00 | -100.00% |
| Dec 31, 2020 | 198.84K | 25.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |